According to Aytu BioScience 's latest financial reports the company's current revenue (TTM) is $98.49 M. In 2022 the company made a revenue of $0.10 B an increase over the years 2021 revenue that were of $81.98 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $98.49 M | -6.71% |
2022 | $0.10 B | 28.78% |
2021 | $81.98 M | 58.63% |
2020 | $51.68 M | 493.49% |
2019 | $8.7 M | 83% |
2018 | $4.75 M | 23.38% |
2017 | $3.85 M | 24.52% |
2016 | $3.09 M | |
2014 | $0 M | -42.86% |
2013 | $0 M | 0% |
2012 | $0 M | |
2011 | N/A | |
2010 | N/A | -100% |
2009 | $0 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Rollins ROL | $3.16 B | 3,111.85% | ๐บ๐ธ USA |
Stride (K12 Education)
LRN | $1.98 B | 1,919.71% | ๐บ๐ธ USA |